ATG is a polyclonal anti‑T‑cell antibody mixture that binds T‑cell antigens (e.g., CD2, CD3, CD4, CD8) and depletes T cells via complement activation, ADCC, and phagocytic clearance; it does not specifically target HLA‑DR, so HLA‑DR–expressing cells are not directly killed.